# N-acetyl-cysteine (NAC) and Kidney Graft Function

> **NCT00998972** · PHASE3 · COMPLETED · sponsor: **Institut d'Anesthesiologie des Alpes Maritimes** · enrollment: 236 (actual)

## Conditions studied

- Brain Death
- Chronic Renal Insufficiency

## Interventions

- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT00998972
- **Lead sponsor:** Institut d'Anesthesiologie des Alpes Maritimes
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2010-12
- **Final completion:** 2011-06
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2011-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00998972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00998972, "N-acetyl-cysteine (NAC) and Kidney Graft Function". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00998972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*